A detailed history of Atom Investors LP transactions in Geron Corp stock. As of the latest transaction made, Atom Investors LP holds 15,753 shares of GERN stock, worth $17,643. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,753
Holding current value
$17,643
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$1.1 - $1.47 $17,328 - $23,156
15,753 New
15,753 $21,000
Q1 2025

May 15, 2025

BUY
$1.59 - $3.6 $23,385 - $52,948
14,708 New
14,708 $23,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $423M
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Atom Investors LP Portfolio

Follow Atom Investors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Atom Investors LP with notifications on news.